FATE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.04%

Insider Buying (Last 12 Months): $285,823.60

Insider Selling (Last 12 Months): $278,392.35

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

^$4.80

▼ -0.24 (-4.76%)

As of 04/19/2024 01:10 PM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Fate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/29/2024	Edward J. Dulac, III	CFO	Sell	1,849	$5.00	$9,245.00	103,926
1/9/2024	Bahram Valamehr	Insider	Sell	11,271	$4.38	$49,366.98	158,069
1/9/2024	Cindy Tahl	General Counsel	Sell	10,874	$4.37	$47,519.38	142,361
1/9/2024	Edward J. Dulac, III	CFO	Sell	7,028	$4.37	$30,712.36	105,775
1/9/2024	J. Scott Wolchko	CEO	Sell	14,391	$4.37	$62,888.67	371,248
12/26/2023	Redmile Group, Llc	Director	Buy	44,630	$3.72	$166,023.60	13,180,388
8/18/2023	Edward J. Dulac, III	CFO	Sell	4,718	$2.80	$13,210.40	119,570
8/4/2023	Yuan Xu	Director	Sell	632	$3.71	$2,344.72	9,302
7/5/2023	Brian T Powl	Insider	Sell	3,854	$4.87	$18,768.98	41,146
7/5/2023	Edward J. Dulac, III	CFO	Sell	5,182	$4.83	$25,029.06	124,288
6/14/2023	Yuan Xu	Director	Sell	3,460	$5.58	$19,306.80	9,934
4/20/2023	Redmile Group, Llc	Director	Buy	20,000	$5.99	$119,800.00	12,879,119
4/18/2023	Yu-Waye Chu	Insider	Sell	2,532	$6.57	$16,635.24	140,676
4/14/2023	Redmile Group, Llc	Director	Buy	25,700	$6.00	$154,200.00	12,859,119
1/13/2023	John Mendlein	Director	Buy	36,631	$5.43	$198,906.33	282,770
1/11/2023	John Mendlein	Director	Buy	88,048	$5.67	$499,232.16	246,139
1/10/2023	Bahram Valamehr	Insider	Sell	10,917	$5.24	$57,205.08	168,917
1/10/2023	Cindy Tahl	General Counsel	Sell	11,553	$5.24	$60,537.72	177,598
1/10/2023	Edward J. Dulac, III	CFO	Sell	7,331	$5.24	$38,414.44	129,470
1/10/2023	J. Scott Wolchko	CEO	Sell	45,907	$5.24	$240,552.68	385,639
8/18/2022	Edward J. Dulac, III	CFO	Sell	5,135	$29.81	$153,074.35	136,801
7/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$32.88	$986,400.00	431,546
7/7/2022	Bahram Valamehr	Insider	Sell	17,158	$30.23	$518,686.34	179,834
7/5/2022	Mark Plavsic	Insider	Sell	3,719	$24.61	$91,524.59	127,123
6/7/2022	Shefali Agarwal	Director	Sell	841	$21.89	$18,409.49	1,840
6/3/2022	John Mendlein	Director	Sell	1,364	$22.79	$31,085.56	158,091
4/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$35.00	$1,050,000.00	431,546
4/19/2022	Yu-Waye Chu	Insider	Sell	4,062	$35.37	$143,672.94	151,033
4/1/2022	Cindy Tahl	General Counsel	Sell	25,000	$38.85	$971,250.00	189,151
3/10/2022	John Mendlein	Director	Sell	31,562	$35.02	$1,105,301.24
1/20/2022	J. Scott Wolchko	CEO	Sell	30,000	$40.21	$1,206,300.00
1/11/2022	Edward J. Dulac, III	CFO	Sell	1,770	$48.45	$85,756.50
1/11/2022	Yu-Waye Chu	VP	Sell	3,965	$48.51	$192,342.15
1/10/2022	Bahram Valamehr	Insider	Sell	5,596	$46.38	$259,542.48
1/10/2022	Cindy Tahl	General Counsel	Sell	7,738	$46.43	$359,275.34
1/10/2022	J. Scott Wolchko	CEO	Sell	34,156	$46.86	$1,600,550.16
12/20/2021	Edward J. Dulac, III	CFO	Sell	15,977	$60.00	$958,620.00
12/13/2021	Bahram Valamehr	Insider	Sell	25,000	$47.66	$1,191,500.00
12/10/2021	Yu-Waye Chu	VP	Sell	7,500	$51.46	$385,950.00
11/18/2021	J. Scott Wolchko	CEO	Sell	20,000	$54.27	$1,085,400.00
10/21/2021	J. Scott Wolchko	CEO	Sell	30,000	$60.22	$1,806,600.00
10/1/2021	Cindy Tahl	General Counsel	Sell	50,000	$58.83	$2,941,500.00
9/28/2021	Edward J. Dulac, III	CFO	Sell	19,460	$62.53	$1,216,833.80
8/19/2021	Edward J. Dulac, III	CFO	Sell	3,474	$88.26	$306,615.24	56,076
8/19/2021	J. Scott Wolchko	CEO	Sell	20,000	$88.01	$1,760,200.00
7/22/2021	J. Scott Wolchko	CEO	Sell	30,000	$86.05	$2,581,500.00
6/14/2021	Bahram Valamehr	Insider	Sell	25,000	$89.32	$2,233,000.00	111,896
4/23/2021	J. Scott Wolchko	CEO	Sell	30,000	$85.24	$2,557,200.00	423,793
4/16/2021	Yu-Waye Chu	VP	Sell	3,275	$83.30	$272,807.50	67,200

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	9,293,363	$34.76M	0.0%	-14.8%	9.365%
3/1/2024	Goldman Sachs Group Inc.	590,993	$2.21M	0.0%	+19.5%	0.596%
2/16/2024	Price T Rowe Associates Inc. MD	54,357	$0.20M	0.0%	-94.4%	0.055%
2/16/2024	GSA Capital Partners LLP	43,003	$0.16M	0.0%	-83.0%	0.044%
2/15/2024	Legal & General Group Plc	17,630	$66K	0.0%	-67.7%	0.018%
2/15/2024	Barclays PLC	359,375	$1.34M	0.0%	+202.6%	0.364%
2/15/2024	Vanguard Group Inc.	9,293,363	$34.76M	0.0%	-14.8%	9.425%
2/15/2024	Voya Investment Management LLC	93,313	$0.35M	0.0%	+14.0%	0.095%
2/15/2024	Nuveen Asset Management LLC	314,571	$1.18M	0.0%	+9.6%	0.319%
2/15/2024	Price T Rowe Associates Inc. MD	54,357	$0.20M	0.0%	-94.4%	0.055%
2/15/2024	Bayesian Capital Management LP	19,636	$73K	0.0%	-48.6%	0.020%
2/15/2024	Brevan Howard Capital Management LP	38,230	$0.14M	0.0%	+120.5%	0.039%
2/14/2024	Royal Bank of Canada	27,188	$0.10M	0.0%	+89.4%	0.028%
2/14/2024	Point72 Asset Management L.P.	3,489,163	$13.05M	0.0%	+4,653.6%	3.539%
2/14/2024	Cubist Systematic Strategies LLC	214,345	$0.80M	0.0%	+515.9%	0.217%
2/14/2024	Pennant Investors LP	146,100	$0.55M	0.1%	N/A	0.148%
2/14/2024	Putnam Investments LLC	244,684	$0.92M	0.0%	+83.6%	0.248%
2/14/2024	Superstring Capital Management LP	847,823	$3.17M	2.3%	N/A	0.860%
2/14/2024	Balyasny Asset Management L.P.	39,836	$0.15M	0.0%	-72.7%	0.040%
2/14/2024	Sei Investments Co.	18,066	$68K	0.0%	N/A	0.018%
2/14/2024	Shell Asset Management Co.	59,302	$0.22M	0.0%	-23.2%	0.060%
2/14/2024	Vestal Point Capital LP	1,290,000	$4.83M	0.5%	N/A	1.308%
2/13/2024	Northern Trust Corp	708,589	$2.65M	0.0%	-43.2%	0.719%
2/13/2024	Tower Research Capital LLC TRC	15,233	$57K	0.0%	-62.7%	0.015%
2/13/2024	Goldman Sachs Group Inc.	590,993	$2.21M	0.0%	+19.5%	0.599%
2/13/2024	The Manufacturers Life Insurance Company	34,898	$0.13M	0.0%	-65.3%	0.035%
2/13/2024	California State Teachers Retirement System	13,950	$52K	0.0%	-84.2%	0.014%
2/12/2024	Bruce & Co. Inc.	143,000	$0.54M	0.2%	-28.5%	0.145%
2/12/2024	Stifel Financial Corp	43,950	$0.16M	0.0%	-31.5%	0.045%
2/12/2024	RPO LLC	12,307	$46K	0.1%	N/A	0.012%
2/12/2024	Hsbc Holdings PLC	78,747	$0.30M	0.0%	-28.7%	0.080%
2/9/2024	US Bancorp DE	7,991	$30K	0.0%	+232.3%	0.008%
2/9/2024	Corient Private Wealth LLC	29,649	$0.11M	0.0%	-5.1%	0.030%
2/9/2024	UBS Group AG	176,305	$0.66M	0.0%	+164.3%	0.179%
2/9/2024	Norges Bank	42,672	$0.16M	0.0%	N/A	0.043%
2/8/2024	Panagora Asset Management Inc.	356,740	$1.33M	0.0%	-16.4%	0.362%
2/8/2024	Vanguard Personalized Indexing Management LLC	12,357	$46K	0.0%	-13.9%	0.013%
2/7/2024	Dimensional Fund Advisors LP	320,774	$1.20M	0.0%	-55.1%	0.325%
2/7/2024	BNP Paribas Financial Markets	23,380	$87K	0.0%	-90.3%	0.024%
2/7/2024	Monaco Asset Management SAM	2,183,228	$8.17M	2.4%	+18.1%	2.214%
2/6/2024	Charles Schwab Investment Management Inc.	983,019	$3.68M	0.0%	+10.9%	0.997%
2/6/2024	National Bank of Canada FI	7,000	$26K	0.0%	-41.7%	0.007%
2/5/2024	Victory Capital Management Inc.	12,504	$47K	0.0%	+22.8%	0.013%
2/5/2024	Russell Investments Group Ltd.	233,748	$0.87M	0.0%	+34.0%	0.237%
1/31/2024	Knights of Columbus Asset Advisors LLC	32,184	$0.12M	0.0%	+100.0%	0.033%
1/31/2024	Federated Hermes Inc.	1,849,872	$6.92M	0.0%	-24.5%	1.876%
1/26/2024	Cerity Partners LLC	32,174	$0.12M	0.0%	N/A	0.033%
1/25/2024	Nisa Investment Advisors LLC	16,840	$63K	0.0%	+1,069.4%	0.017%
1/17/2024	Assenagon Asset Management S.A.	163,097	$0.61M	0.0%	-57.2%	0.165%
1/12/2024	SG Americas Securities LLC	90,553	$0.34M	0.0%	+23.0%	0.092%
1/11/2024	Epiq Partners LLC	10,071	$38K	0.0%	N/A	0.010%
1/5/2024	Exchange Traded Concepts LLC	63,725	$0.24M	0.0%	+34.0%	0.065%
12/19/2023	Public Employees Retirement System of Ohio	154,178	$0.33M	0.0%	+14.7%	0.156%
12/18/2023	Vanguard Group Inc.	10,908,351	$23.13M	0.0%	-7.0%	11.063%
11/30/2023	American Century Companies Inc.	37,062	$79K	0.0%	+74.7%	0.038%
11/24/2023	Deutsche Bank AG	44,719	$95K	0.0%	-81.8%	0.045%
11/22/2023	Graham Capital Management L.P.	21,690	$46K	0.0%	-84.8%	0.022%
11/21/2023	Walleye Capital LLC	101,985	$0.22M	0.0%	-73.8%	0.103%
11/17/2023	Diversified Trust Co	12,287	$26K	0.0%	-48.0%	0.012%
11/17/2023	Jacobs Levy Equity Management Inc.	2,389,123	$5.07M	0.0%	+2.3%	2.423%
11/16/2023	Tudor Investment Corp Et Al	50,187	$0.11M	0.0%	-8.1%	0.051%
11/16/2023	Public Employees Retirement System of Ohio	154,178	$0.33M	0.0%	+14.7%	0.156%
11/15/2023	GSA Capital Partners LLP	253,429	$0.54M	0.0%	+30.4%	0.257%
11/15/2023	Laurion Capital Management LP	35,173	$75K	0.0%	+128.6%	0.036%
11/15/2023	Legal & General Group Plc	54,531	$0.12M	0.0%	-32.1%	0.055%
11/15/2023	Ameriprise Financial Inc.	275,492	$0.58M	0.0%	+11.0%	0.279%
11/15/2023	AQR Capital Management LLC	332,911	$0.71M	0.0%	N/A	0.338%
11/14/2023	Schonfeld Strategic Advisors LLC	19,200	$41K	0.0%	N/A	0.019%
11/14/2023	California State Teachers Retirement System	88,221	$0.19M	0.0%	-9.3%	0.089%
11/14/2023	Tower Research Capital LLC TRC	40,826	$87K	0.0%	+64.6%	0.041%
11/14/2023	Qube Research & Technologies Ltd	388,256	$0.82M	0.0%	+117.3%	0.394%
11/13/2023	Algert Global LLC	91,864	$0.20M	0.0%	-82.9%	0.093%
11/13/2023	Federated Hermes Inc.	2,451,544	$5.20M	0.0%	-0.7%	2.486%
11/13/2023	Stifel Financial Corp	64,129	$0.14M	0.0%	-7.4%	0.065%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	444,038	$0.94M	0.0%	-3.3%	0.450%
11/13/2023	Dark Forest Capital Management LP	425,901	$0.90M	0.1%	+477.9%	0.432%
11/13/2023	Acadian Asset Management LLC	2,149,597	$4.56M	0.0%	+135.5%	2.180%
11/13/2023	Hsbc Holdings PLC	110,392	$0.24M	0.0%	+212.3%	0.112%
11/13/2023	Aigen Investment Management LP	42,798	$91K	0.0%	N/A	0.043%
11/13/2023	Invesco Ltd.	125,587	$0.27M	0.0%	+5.7%	0.127%
11/13/2023	FMR LLC	307,630	$0.65M	0.0%	-42.6%	0.312%
11/9/2023	Deutsche Bank AG	44,719	$95K	0.0%	-81.8%	0.045%
11/9/2023	UBS Group AG	66,710	$0.14M	0.0%	-74.3%	0.068%
11/8/2023	State Board of Administration of Florida Retirement System	340,554	$0.72M	0.0%	+1,121.7%	0.346%
11/8/2023	Vanguard Personalized Indexing Management LLC	14,354	$30K	0.0%	N/A	0.015%
11/8/2023	Shell Asset Management Co.	77,199	$0.16M	0.0%	+1,962.5%	0.078%
11/8/2023	Charles Schwab Investment Management Inc.	886,715	$1.88M	0.0%	+39.2%	0.900%
11/7/2023	Quantbot Technologies LP	47,500	$0.10M	0.0%	+410.8%	0.048%
11/7/2023	Monaco Asset Management SAM	1,847,944	$3.92M	1.2%	+83.8%	1.875%
11/7/2023	Barclays PLC	118,751	$0.25M	0.0%	-75.2%	0.120%
11/7/2023	Fox Run Management L.L.C.	12,000	$25K	0.0%	N/A	0.012%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	60,299	$0.13M	0.0%	+15.1%	0.061%
11/6/2023	Assenagon Asset Management S.A.	380,737	$0.81M	0.0%	+281.3%	0.386%
10/31/2023	Panagora Asset Management Inc.	426,585	$0.90M	0.0%	+33.5%	0.433%
10/27/2023	TD Asset Management Inc	141,652	$0.30M	0.0%	+100.0%	0.144%
10/25/2023	Brown Advisory Inc.	19,364	$41K	0.0%	+53.3%	0.020%
10/24/2023	Bank of New York Mellon Corp	312,788	$0.66M	0.0%	-3.4%	0.317%
10/19/2023	Simplicity Solutions LLC	12,012	$25K	0.0%	N/A	0.012%
10/18/2023	Exchange Traded Concepts LLC	47,566	$0.10M	0.0%	+85.7%	0.048%
10/16/2023	Herbst Group LLC	15,700	$33K	0.0%	N/A	0.016%

Data available starting January 2016

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $4.80

$4.80

$5.11

50 Day Range

MA: $6.95

$5.04

$8.35

52 Week Range

Now: $4.80

$1.63

$8.83

Volume

660,347 shs

Average Volume

2,752,461 shs

Market Capitalization

$546.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Fate Therapeutics?: Fate Therapeutics' top insider investors include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
John Mendlein (Director)
Bahram Valamehr (Insider)
Cindy Tahl (General Counsel)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Mark Plavsic (Insider)
Brian T Powl (Insider)
Yuan Xu (Director)
Shefali Agarwal (Director)
Learn More about top insider investors at Fate Therapeutics.